학술논문

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Document Type
Article
Author
Bardymova, TatianaBarrientos Perez, MargaritaBethin, KathleenBjornstad, PetterBondar, IrinaChen, MimiChoi, Jin-HoClements, Mark AColomar, Javier RicardoDaniels, MarkDeerochanawong, ChaicharnDesai, Vivek SDesmangles, Jean-Claude GDillon, Robert GDixit, Naznin MDu, HongweiEdelen, RachelEspinoza Peralta, DiegoFelipe Gacioppo, María VerónicaFerraz, Tania Maria Bulcão LousadaGalkina, GalinaGallagher, Mary PatriciaGeorge, MinuGonzalez, EdgarGottschalk, Michael EverettGuido, GiancarloHassan, Amir AliHershkovitz, EliHuerta-Saenz, Lina PHwang, Jin SoonIbarra Gomez, Jaime OrlandoIrizarry Gonzalez, LydiaJain, NinaJelley, David HKim, Ho-SeongKovalenko, TatianaLaffel, Lori Michelle BLeichter, Steven BLiberatore Jr, Raphael Del RoioLynch, JaneMahmud, Farid HussainMalievskiy, Oleg ArturovichMuir, AndrewNelson, Bryce ANevarez Ruiz, Luis AlejandroOlson, Micah LPelayo Orozco, Emilia SusanaPeterkova, ValentinaRamírez Mendoza, Fernando RamónReddy, Konda MohanRodriguez, HenrySaenz, Javier AndresSamoilova, JuliaSchwab, Karl-OtfriedShah, Sejal HShehadeh, NaimShoemaker, Ashley HSkorodok, YuliaSobolev, AleksandrSolís, Silvana ErnestinaSrinivasan, ShylajaTamborlane, William VTsalikian, EvaValeeva, FaridaVance, Carl DVelasquez-Mieyer, Pedro AViolante Ortiz, Rafael MargaritoVotyakova, OlgaWei, HaiyanWeinstock, Ruth SWheeler, Mark DWicklow, Brandy AlexandraWilli, Steven MWintergerst, Kupper AWolf, Risa MWood, Jamie RuthYaliwal, ChandanYupanqui Lozno, HernánLaffel, Lori MDanne, ThomasKlingensmith, Georgeanna JWilli, StevenZeitler, PhilipNeubacher, DietmarMarquard, Jan
Source
In The Lancet Diabetes & Endocrinology March 2023 11(3):169-181
Subject
Primary Research
Articles
Language
ISSN
2213-8587